Periarticular Administration of Dexamethasone to Improve Post-operative Pain, Function, Nausea, Hospitalization Length, and Risk of Complications in Patients Undergoing Hip Arthroplasty - A Randomized Trial
Who is this study for? Patients with Femoral Neck Fractures
What treatments are being studied? Dexamethasone
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 4
SUMMARY
The investigators are going to evaluate if periarticular corticosteroid injection during endoprothesis implantation can lead to any advantage to the patients, namely if it can reduce post-operative pain, lenght and cost of hospitalisation, use of analgesics drugs.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 50
Maximum Age: 90
Healthy Volunteers: f
View:
• Patients undergoing unilateral cemented hip endoprosthesis for femoral neck fracture
• Patients aged 50-90 years old
• Patients with a BMI \>18.5 and \<35
• Patients able to provide informed consent and follow all the study procedures as indicated by the protocol
• Informed Consent as documented by signature
Locations
Other Locations
Switzerland
Christian Candrian
RECRUITING
Lugano
Contact Information
Primary
Christian MD Candrian, Prof.
Gabriela.Induni-Lang@eoc.ch
0041918117029
Backup
Gabriela Induni-Lang
Gabriela.Induni-Lang@eoc.ch
0041918117029
Time Frame
Start Date: 2021-12-10
Estimated Completion Date: 2026-11-01
Participants
Target number of participants: 110
Treatments
Experimental: Dexamethasone group
Patient in this group will receive administration of 9 mg dexamethasone injected in the peri-articular tissues after the bone cut for hip endoprosthesis
No_intervention: Routine care
In this group only routinely performed anaesthesia protocol will be provided
Related Therapeutic Areas
Sponsors
Leads: Ente Ospedaliero Cantonale, Bellinzona